Eribulin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1128 publications

A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making.

A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making.

Journal: Palliative & supportive care

Published: May 14, 2026

The Evolving Landscape of Systemic Therapy for Liposarcoma.

The Evolving Landscape of Systemic Therapy for Liposarcoma.

Journal: Cancers

Published: April 21, 2026

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report.

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report.

Journal: Anti-cancer drugs

Published: April 15, 2026

Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: March 30, 2026

Across Borders and Histologies: Rethinking Endpoints for Vascular Sarcoma Trials.

Across Borders and Histologies: Rethinking Endpoints for Vascular Sarcoma Trials.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 25, 2026

Efficacy and safety of eribulin therapy for breast cancer with liver metastasis: a retrospective real-world study.

Efficacy and safety of eribulin therapy for breast cancer with liver metastasis: a retrospective real-world study.

Journal: Frontiers in oncology

Published: January 25, 2026

Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight cases.

Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight cases.

Journal: Rare tumors

Published: January 24, 2026

Effects of Eribulin on Epithelial-Mesenchymal Plasticity in Patient-Derived Breast Cancer Cultures and Excised Tissues.

Effects of Eribulin on Epithelial-Mesenchymal Plasticity in Patient-Derived Breast Cancer Cultures and Excised Tissues.

Journal: Cancers

Published: January 10, 2026

Does coordinated targeting of metabolism and autophagy, modulated by microtubule dynamics, influence therapeutic vulnerability to eribulin in glioblastoma?

Does coordinated targeting of metabolism and autophagy, modulated by microtubule dynamics, influence therapeutic vulnerability to eribulin in glioblastoma?

Journal: Translational cancer research

Published: January 07, 2026

Long-term survival with eribulin in an elderly patient with inoperable retroperitoneal well-differentiated liposarcoma: a case report and literature review.

Long-term survival with eribulin in an elderly patient with inoperable retroperitoneal well-differentiated liposarcoma: a case report and literature review.

Journal: Frontiers in oncology

Published: December 29, 2025

The Role of Natural Product Chemistry in Drug Discovery: Two Decades of Progress and Perspectives.

The Role of Natural Product Chemistry in Drug Discovery: Two Decades of Progress and Perspectives.

Journal: Journal of natural products

Published: December 26, 2025

Modern synthetic pathways towards eribulin and its subunits.

Modern synthetic pathways towards eribulin and its subunits.

Journal: Beilstein journal of organic chemistry

Published: December 17, 2025

Showing 1-12 of 1,128

Last Updated: 06/30/2026